Peer-influenced content. Sources you trust. No registration required. This is HCN.

Toxicological SciencesIntegrating Experimental Data and Mechanistic Modeling to Assess Potential Lead Exposure from Tampon Use

ℹ️ Observational Association Only Evidence
Trace lead detected in tampons has generated patient concern about menstrual product safety. This study combined experimental partitioning data with a mass-balance compartmental model to estimate biologically relevant exposure during a four-hour wear scenario.


Clinical Considerations

  • Lead in menstrual fluid preferentially partitioned to the red blood cell fraction, with plasma-bound lead predominantly protein-bound — comparable to systemic blood distribution.
  • Under conservative model assumptions, less than 1 ng (<0.3%) of theoretically released lead was estimated to be available for vaginal tissue absorption per four-hour wear period.
  • The majority of released lead was modeled as reabsorbed into the tampon during fluid uptake.
  • Sensitivity and alternative release scenario analyses showed predicted tissue uptake remained minimal across plausible conditions.
  • Author disclosures include Procter & Gamble affiliation; this is industry-sponsored modeling work, not direct in vivo human measurement.

Practice Applications

  • Recognize the distinction between chemical presence in a product and biologically relevant systemic exposure.
  • Interpret modeled estimates as hypothesis-generating, pending independent in vivo confirmation.
  • Reassure patients that current modeled exposures fall well below thresholds of concern, while acknowledging evidence is still emerging.
  • Monitor the literature for upcoming independent validation studies and regulatory commentary.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form